Background. The aim of the study was to evaluate the efficacy of psychological interventions in adults with moderate and severe asthma. In addition, personality traits were taken into consideration. Material and methods. Eighteen adults with moderate or severe asthma were divided into experimental and control group. The division was performed on the basis of attendance at psychotherapy sessions. The assessment of asthma control was based on interview, physical examination and lung function testing. In psychological interview pre- and post-therapy quality of life was evaluated with: Saint George’s Hospital Respiratory Questionnaire (SGRQ), Acceptance of Illness Scale (AIS) and Courtauld Emotional Control Scale (CECS). The assessment of...
Background The role of fibrinolysis and serotonin in glomerulonephritis is still the matter of contr...
Introduction: Schizophrenia is one of the most severe mental disorders. It is characterized by a chr...
Risperidone is approved by FDA for treatment of schizophrenia (1993) or to treat bipolar I (2003) ma...
The patients with acute myocardial infarction have many emotional and behavioral problems and some o...
Background. The most significant aim of treatment for Parkinson’s disease is the improvement of func...
Introduction: Many of the symptoms of depression in men can be placed in the category of other menta...
W artykule autorka prezentuje specyficzne elementy procesu terapeutycznego osób, u których współist...
Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. Clinical symptoms li...
Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterised bya heterogeneous clin...
Jadłowstręt psychiczny i żarłoczność psychiczna to często występujące zaburzenia psychiczne w popula...
Admission. Myocardial infraction belongs to group of acute coronary syndromes which are characterize...
Aim: Exploring how children aged 9–10 years perceive a person who feel good and bad andfactors influ...
Przedstawiona praca badawcza jest ukierunkowana na analizę funkcjonowania osób uzależnionych od alko...
Background: The aetiology of chronic thromboembolic pulmonary hypertension (CTEPH) is not clearly un...
Intoduction. Gynecomastia is a benign abnormal enlargement of breast tissue in males. This enlargeme...
Background The role of fibrinolysis and serotonin in glomerulonephritis is still the matter of contr...
Introduction: Schizophrenia is one of the most severe mental disorders. It is characterized by a chr...
Risperidone is approved by FDA for treatment of schizophrenia (1993) or to treat bipolar I (2003) ma...
The patients with acute myocardial infarction have many emotional and behavioral problems and some o...
Background. The most significant aim of treatment for Parkinson’s disease is the improvement of func...
Introduction: Many of the symptoms of depression in men can be placed in the category of other menta...
W artykule autorka prezentuje specyficzne elementy procesu terapeutycznego osób, u których współist...
Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. Clinical symptoms li...
Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterised bya heterogeneous clin...
Jadłowstręt psychiczny i żarłoczność psychiczna to często występujące zaburzenia psychiczne w popula...
Admission. Myocardial infraction belongs to group of acute coronary syndromes which are characterize...
Aim: Exploring how children aged 9–10 years perceive a person who feel good and bad andfactors influ...
Przedstawiona praca badawcza jest ukierunkowana na analizę funkcjonowania osób uzależnionych od alko...
Background: The aetiology of chronic thromboembolic pulmonary hypertension (CTEPH) is not clearly un...
Intoduction. Gynecomastia is a benign abnormal enlargement of breast tissue in males. This enlargeme...
Background The role of fibrinolysis and serotonin in glomerulonephritis is still the matter of contr...
Introduction: Schizophrenia is one of the most severe mental disorders. It is characterized by a chr...
Risperidone is approved by FDA for treatment of schizophrenia (1993) or to treat bipolar I (2003) ma...